-
-
-
-
-
-
-
Viking Therapeutics (VKTX) Misses Q4 EPS by 48c
-
-
-
-
-
-
-
Viking Therapeutics to Report Financial Results for Third Quarter 2025 on October 22, 2025
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Viking Therapeutic (VKTX)
-
-
-
-
-
-
-
Viking Therapeutics to Report Financial Results for Fourth Quarter and Year-End 2024 on February 5, 2025
-
-
-
-
-
-
-
Ligand Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Viking Therapeutics (VKTX) Tops Q1 EPS by 2c
-
-
-
-
-
-
-
Viking Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
-
1,197,452 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

